Live feed
Filing
SC 13D/A
SC 13D/A0000921895-17-000061·BIOTECHNOLOGY VALUE FUND L P
Schedule 13D ownership disclosure
Cascadian Therapeutics Inc
Security class unavailable · CUSIP: 14740B606
Event date: 2017-01-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-17-000061
- Form type
- SC 13D/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jan 17, 2017
- Reporting period
- Jan 17, 2017
- Description
- Schedule 13D beneficial ownership